Copenhagen
Denmark
56
2023-11-16
44
2024-03-19
These are the the leading inventors for applications assigned to GENMAB A/S:
GENMAB A/S based in Copenhagen, DK has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Monoclonal antibodies directed against programmed death-1 protein and their use in medicine
#2 | 2021-08-19 ✅ Patent 11,814,411 granted on 2023-11-14Nucleic acid molecules encoding binding agents to CD40 and 4-1BB (CD137)
#3 | 2021-06-03 ✅ Patent 11,459,395 granted on 2022-10-04Binding agents binding to PD-L1 and CD137 and use thereof
#4 | 2020-08-06 ✅ Patent 11,084,882 granted on 2021-08-10Multispecific antibodies against CD40 and CD137
#5 | 2020-03-12 ✅ Patent 10,927,181 granted on 2021-02-23Agonistic tumor necrosis factor (TNF) receptor binding agents
#6 | 2019-09-19 ✅ Patent 11,359,015 granted on 2022-06-14Humanized or chimeric CD3 antibodies
#7 | 2017-02-02 ✅ Patent 10,752,695 granted on 2020-08-25Stable IgG4 antibodies
#8 | 2016-03-10 ✅ Patent 9,492,565 granted on 2016-11-15Human antibody drug conjugates against tissue factor
#9 | 2016-02-25 ✅ Patent 9,714,297 granted on 2017-07-25Human antibodies against tissue factor and methods of use thereof
#10 | 2015-11-19 ✅ Patent 9,657,107 granted on 2017-05-23Monoclonal antibodies against c-Met
#11 | 2015-09-17 ✅ Patent 9,598,493 granted on 2017-03-21Human monoclonal antibodies against CD25
#12 | 2015-01-01 ✅ Patent 9,663,578 granted on 2017-05-30Monoclonal antibodies against CD32b
#13 | 2014-11-27 ✅ Patent 9,540,450 granted on 2017-01-10Methods and antibodies for treating cancer
#14 | 2014-10-09 ✅ Patent 10,344,050 granted on 2019-07-09Production of heterodimeric proteins
#15 | 2014-05-22 ✅ Patent 9,458,236 granted on 2016-10-04Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
#16 | 2014-01-30 ✅ Patent 9,540,433 granted on 2017-01-10Human antibodies and antibody-drug conjugates against CD74
#17 | 2013-12-26STABLE IGG4 ANTIBODIES
#18 | 2013-09-10 ✅ Patent 8,529,902 granted on 2013-09-10Human monoclonal antibodies against CD20
#19 | 2013-08-22 ✅ Patent 9,068,011 granted on 2015-06-30Monoclonal antibodies against c-Met
#20 | 2013-08-15 ✅ Patent 9,249,226 granted on 2016-02-02Antibodies against human CD38
#21 | 2013-07-25 ✅ Patent 9,862,769 granted on 2018-01-09Monoclonal antibodies against HER2
#22 | 2013-07-04 ✅ Patent 9,714,294 granted on 2017-07-25Monoclonal antibodies against HER2 epitope
#23 | 2013-04-25 ✅ Patent 9,168,314 granted on 2015-10-27Human antibody drug conjugates against tissue factor
#24 | 2013-04-18NOVEL METHODS FOR TREATING EGFR-ASSOCIATED TUMORS
#25 | 2013-02-14 ✅ Patent 9,150,663 granted on 2015-10-06Heterodimeric antibody Fc-containing proteins and methods for production thereof
#26 | 2012-09-27 ✅ Patent 8,961,968 granted on 2015-02-24Human monoclonal antibodies against CD25
#27 | 2012-06-28 ✅ Patent 8,603,469 granted on 2013-12-10Methods of treating cancer with human monoclonal antibodies against interleukin 8
#28 | 2011-12-08 ✅ Patent 9,150,658 granted on 2015-10-06Human antibodies against tissue factor and methods of use thereof
#29 | 2011-10-20NOVEL METHODS AND ANTIBODIES FOR TREATING CANCER
#30 | 2011-04-28 ✅ Patent 9,187,565 granted on 2015-11-17Antibodies against CD38 for treatment of multiple myeloma
#31 | 2011-04-14METHODS FOR ASSESSING THE RISK OF ADVERSE EVENTS UPON TREATMENT WITH IGG4 ANTIBODIES
#32 | 2011-02-24FUSION OR LINKED PROTEINS WITH EXTENDED HALF LIFE
#33 | 2011-02-17 ✅ Patent 8,802,089 granted on 2014-08-12Monoclonal antibodies against CD32B
#34 | 2010-12-23NON-GLYCOSYLATED RECOMBINANT MONOVALENT ANTIBODIES
#35 | 2010-12-23NOVEL METHODS FOR TREATING EGFR-ASSOCIATED TUMORS
#36 | 2010-12-02 ✅ Patent 9,322,035 granted on 2016-04-26Recombinant IgG4 monovalent antibodies
#37 | 2010-12-02 ✅ Patent 8,105,588 granted on 2012-01-31Human monoclonal antibodies against interleukin 8 (IL-8)
#38 | 2010-11-18METHOD FOR EXTENDING THE HALF-LIFE OF EXOGENOUS OR ENDOGENOUS SOLUBLE MOLECULES
#39 | 2010-10-21STABLE IGG4 ANTIBODIES
#40 | 2010-10-07RECOMBINANT FUCOSE MODIFIED MONOVALENT HALF-ANTIBODIES OBTAINED BY MOLECULAR ENGINEERING
#41 | 2010-06-17 ✅ Patent 9,428,582 granted on 2016-08-30Method of treating rash in patients undergoing anti-EGFR therapy
#42 | 2010-04-29 ✅ Patent 9,212,230 granted on 2015-12-15Bispecific antibodies and methods for production thereof
#43 | 2010-04-15 ✅ Patent 9,040,050 granted on 2015-05-26Combination treatment of CD38-expressing tumors
#44 | 2010-02-18HIGH THROUGHPUT METHODS FOR CHARACTERIZATION OF ANTIBODIES
#45 | 2010-01-21 ✅ Patent 9,580,506 granted on 2017-02-28Potency assays for antibody drug substance binding to an Fc receptor
#46 | 2010-01-21 ✅ Patent 9,309,315 granted on 2016-04-12Therapy with CD4 binding peptides and radiation
#47 | 2010-01-14 ✅ Patent 8,586,041 granted on 2013-11-19Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
#48 | 2009-12-24 ✅ Patent 9,181,344 granted on 2015-11-10Use of effector-function-deficient antibodies for treatment of auto-immune diseases
#49 | 2009-09-29 ✅ Patent 7,595,378 granted on 2009-09-29Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
#50 | 2009-06-18Methods for treating disorders involving monocytes
#51 | 2009-06-11 ✅ Patent 7,829,673 granted on 2010-11-09Antibodies against CD38 for treatment of multiple myeloma
#52 | 2009-03-26 ✅ Patent 8,182,812 granted on 2012-05-22Human monoclonal antibodies against CD25
#53 | 2008-07-10 ✅ Patent 7,585,961 granted on 2009-09-08Nucleic acid encoding human antibodies specific for interleukin 15 (IL-15)
#54 | 2008-07-10 ✅ Patent 7,597,892 granted on 2009-10-06Method for treating psoriasis by administering human antibodies specific for Interleukin 15 (IL-15)
#55 | 2008-05-22 ✅ Patent 7,622,559 granted on 2009-11-24Human monoclonal antibodies against interleukin 8 (IL-8)
#56 | 2006-12-26 ✅ Patent 7,153,507 granted on 2006-12-26Human antibodies specific for interleukin 15 (IL-15)
Also check out GENMAB A/S's (Copenhagen, Denmark) applicant profile with 16 patent applications submitted.
9295 ⎘